Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-26 @ 2:02 AM
NCT ID: NCT02971605
Description: None
Frequency Threshold: 0
Time Frame: Adverse events were assessed from Screening to 1-month post psilocybin session (32-70 days).
Study: NCT02971605
Study Brief: Persisting Effects of Psilocybin
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Psilocybin Participants will be administered a 25 mg/70 kg dose of psilocybin Psilocybin: 25 mg/70 kg Psilocybin 0 None 0 13 3 13 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Thyroid hormone changes SYSTEMATIC_ASSESSMENT Endocrine disorders None View
Cardiac event SYSTEMATIC_ASSESSMENT Cardiac disorders None View